Literature DB >> 18307400

Development of cell therapy strategies to overcome copper toxicity in the LEC rat model of Wilson disease.

Harmeet Malhi1, Brigid Joseph, Michael L Schilsky, Sanjeev Gupta.   

Abstract

AIMS: Therapeutic replacement of organs with healthy cells requires disease-specific strategies. As copper toxicosis due to ATP7B deficiency in Wilson disease produces significant liver injury, disease-specific study of transplanted cell proliferation will offer insights into cell and gene therapy mechanisms. MATERIALS &
METHODS: We used Long-Evans Cinnamon (LEC) rats to demonstrate the effects of liver preconditioning with radiation and ischemia reperfusion, followed by transplantation of healthy Long-Evans Agouti rat hepatocytes and analysis of hepatic atp7b mRNA, bile copper, liver copper and liver histology.
RESULTS: LEC rats without cell therapy or after transplantation of healthy cells without liver conditioning accumulated copper and showed liver disease during the study period. Liver conditioning incorporating hepatic radiation promoted transplanted cell proliferation and reversed Wilson disease parameters, although with interindividual variations and time lags for improvement, which were different from previous results of liver repopulation in healthy animals.
CONCLUSION: Cell therapy will correct genetic disorders characterized by organ damage. However, suitable mechanisms for inducing transplanted cell proliferation will be critical for therapeutic success.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18307400     DOI: 10.2217/17460751.3.2.165

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  19 in total

1.  Wilson's Disease with Neurological Presentation, without Hepatic Involvement in Two Siblings.

Authors:  Mani Kant Kumar; Vijay Kumar; Praphul Kumar Singh
Journal:  J Clin Diagn Res       Date:  2013-06-26

2.  Hepatocyte transplantation.

Authors:  Ragai R Mitry; Robin D Hughes; Anil Dhawan
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

3.  In Atp7b-/- Mice Modeling Wilson's Disease Liver Repopulation With Bone Marrow-Derived Myofibroblasts or Inflammatory Cells and Not Hepatocytes Is Deleterious.

Authors:  Yogeshwar Sharma; Jinghua Liu; Kathleen E Kristian; Antonia Follenzi; Sanjeev Gupta
Journal:  Gene Expr       Date:  2018-07-20

4.  Diagnosis of abnormal biliary copper excretion by positron emission tomography with targeting of (64)Copper-asialofetuin complex in LEC rat model of Wilson's disease.

Authors:  Ralf Bahde; Sorabh Kapoor; Kuldeep K Bhargava; Christopher J Palestro; Sanjeev Gupta
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

Review 5.  Human hepatocyte transplantation: current experience and future challenges.

Authors:  Anil Dhawan; Juliana Puppi; Robin D Hughes; Ragai R Mitry
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

Review 6.  Animal models of Wilson disease.

Authors:  Emily Reed; Svetlana Lutsenko; Oliver Bandmann
Journal:  J Neurochem       Date:  2018-06-26       Impact factor: 5.372

7.  Demonstrating Potential of Cell Therapy for Wilson's Disease with the Long-Evans Cinnamon Rat Model.

Authors:  Fadi Luc Jaber; Yogeshwar Sharma; Sanjeev Gupta
Journal:  Methods Mol Biol       Date:  2017

8.  Bile salt-induced pro-oxidant liver damage promotes transplanted cell proliferation for correcting Wilson disease in the Long-Evans Cinnamon rat model.

Authors:  Brigid Joseph; Sorabh Kapoor; Michael L Schilsky; Sanjeev Gupta
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

Review 9.  Stem cell therapies for the treatment of radiation-induced normal tissue side effects.

Authors:  Marc Benderitter; Fabio Caviggioli; Alain Chapel; Robert P Coppes; Chandan Guha; Marco Klinger; Olivier Malard; Fiona Stewart; Radia Tamarat; Peter van Luijk; Charles L Limoli
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

Review 10.  Cell therapy to remove excess copper in Wilson's disease.

Authors:  Sanjeev Gupta
Journal:  Ann N Y Acad Sci       Date:  2014-05       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.